🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/02/1980 | 1,72 | 1,78 | 1,72 | 1,78 | +3,86% | 3,86% | 3.101.242 |
| 19/02/1980 | 1,74 | 1,74 | 1,72 | 1,72 | -1,52% | 1,52% | 2.414.592 |
| 15/02/1980 | 1,77 | 1,77 | 1,74 | 1,74 | -1,87% | 1,87% | 2.754.144 |
| 14/02/1980 | 1,78 | 1,80 | 1,76 | 1,78 | -0,19% | 2,24% | 2.063.722 |
| 13/02/1980 | 1,83 | 1,83 | 1,78 | 1,78 | -2,72% | 2,90% | 2.988.058 |
| 12/02/1980 | 1,78 | 1,83 | 1,78 | 1,83 | +2,60% | 2,97% | 2.191.997 |
| 11/02/1980 | 1,75 | 1,78 | 1,75 | 1,78 | +1,89% | 1,89% | 3.203.107 |
| 08/02/1980 | 1,76 | 1,80 | 1,74 | 1,75 | -0,56% | 3,39% | 5.549.789 |
| 07/02/1980 | 1,81 | 1,81 | 1,76 | 1,76 | -2,75% | 2,93% | 4.278.355 |
| 06/02/1980 | 1,81 | 1,84 | 1,79 | 1,81 | -0,18% | 2,56% | 4.508.496 |
| 05/02/1980 | 1,81 | 1,83 | 1,81 | 1,81 | +0,18% | 1,10% | 3.406.838 |
| 04/02/1980 | 1,80 | 1,81 | 1,80 | 1,81 | +0,93% | 0,74% | 2.840.918 |
| 01/02/1980 | 1,81 | 1,81 | 1,77 | 1,79 | -1,28% | 2,20% | 3.648.298 |
| 31/01/1980 | 1,85 | 1,87 | 1,82 | 1,82 | -1,80% | 2,87% | 2.373.091 |
| 30/01/1980 | 1,83 | 1,85 | 1,82 | 1,85 | +1,27% | 1,82% | 1.795.853 |
| 29/01/1980 | 1,84 | 1,84 | 1,81 | 1,83 | -1,07% | 1,80% | 2.701.325 |
| 28/01/1980 | 1,85 | 1,85 | 1,81 | 1,85 | -0,54% | 2,33% | 2.350.454 |
| 25/01/1980 | 1,86 | 1,87 | 1,85 | 1,86 | -0,35% | 0,89% | 1.444.982 |
| 24/01/1980 | 1,86 | 1,89 | 1,84 | 1,86 | +0,00% | 2,31% | 3.271.018 |
| 23/01/1980 | 1,86 | 1,88 | 1,85 | 1,86 | +0,36% | 1,61% | 3.369.110 |
| 22/01/1980 | 1,87 | 1,88 | 1,84 | 1,86 | -0,89% | 1,95% | 8.945.309 |
| 21/01/1980 | 1,87 | 1,88 | 1,86 | 1,87 | +0,18% | 0,89% | 2.173.133 |
| 18/01/1980 | 1,88 | 1,88 | 1,85 | 1,87 | -0,71% | 1,41% | 5.708.246 |
| 17/01/1980 | 1,93 | 1,93 | 1,88 | 1,88 | -2,24% | 2,75% | 2.056.176 |
| 16/01/1980 | 1,93 | 1,95 | 1,92 | 1,93 | -0,17% | 1,55% | 1.927.901 |
| 15/01/1980 | 1,95 | 1,95 | 1,93 | 1,93 | -1,02% | 1,19% | 1.531.757 |
| 14/01/1980 | 1,95 | 1,97 | 1,95 | 1,95 | +0,69% | 1,36% | 1.486.483 |
| 11/01/1980 | 1,99 | 2,00 | 1,93 | 1,93 | -2,99% | 3,82% | 2.788.099 |
| 10/01/1980 | 1,97 | 2,00 | 1,97 | 1,99 | +1,00% | 1,34% | 2.995.603 |
| 09/01/1980 | 1,99 | 2,00 | 1,97 | 1,97 | -0,66% | 1,50% | 3.248.381 |